Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

Share Price is delayed by 15 minutes
Get Live Data
2.44    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.015 (0.617%)
Market Cap: $8.05b
CBKD Live PriceLast checked at - London Stock Exchange

Intraday Com.int.bk.regs Share Chart

  • This share is an international stock.

Stand Alone Financials

13 Aug 2009 07:00

RNS Number : 3625X
Commercial Intnl Bank (Egypt) SAE
12 August 2009
 



Commercial International Bank (Egypt) S.A.E.

Financial Statements

June 30, 2009

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

FINANCIAL POSITION 

 

 

 

 

As of June 30 2009

Amounts in L.E.

Note

30-June 2009

31-Dec-2008

Assets

Cash & Due From Central Bank

5

4,114,701,616

4,473,011,942

Due From Banks

6

7,807,348,485

6,411,397,744

Treasury Bills & Other Governmental Notes

7

11,154,734,981

12,449,007,406

Trading Financial Assets

8

774,306,116

497,554,487

Loans & Overdrafts 

12&11

27,161,846,172

26,330,327,878

Financial Investments:

Available for Sale 

9

7,575,555,122

2,762,232,984

Held to Maturity 

9

638,693,110

681,263,274

Financial Investments in Subsidiary and associated 

companies

14

1,138,493,937

1,138,332,672

Debit Balances and Other Assets

16

754,460,068

942,621,482

Deferred Tax

28

31,220,934

21,840,568

Fixed Assets (Net)

17

773,811,530

715,251,587

Total Assets

62,355,894,834

57,127,732,816

Liabilities & Shareholders' Equity

Liabilities

Due to Banks

18

3,573,891,247

213,470,012

Customer Deposits

19

50,929,446,540

48,938,109,663

Financial Derivatives

13

308,473,371

636,914,744

Credit Balances & Other Liabilities

20

869,125,264

1,235,780,102

Long Term Loans

21

108,168,665

109,273,933

Other Provisions

22

375,312,389

363,218,186

Total Liabilities

56,164,417,476

51,496,766,640

Shareholders' Equity

Issued & Paid- in Capital

23

2,925,000,000

2,925,000,000

Reserves

23

2,207,473,741

1,006,080,499

Reserve for employee stock ownership plan (ESOP)

126,996,263

86,727,903

Retained Earnings

(1,942,684)

(1,942,684)

Total Shareholders' Equity

5,257,527,320

4,015,865,718

Net Profit of the Period/ Year

933,950,038

1,615,100,458

Total Shareholders' Equity & Net Profit

6,191,477,358

5,630,966,176

Total Liabilities & Shareholders' Equity 

62,355,894,834

57,127,732,816

Contingent Liabilities & commitments 

Letters of Credit, Guarantees and Other Commitments

24

12,991,908,320

13,290,994,705

INCOME STATEMENT

As of June. 30 2009

June 30, 2009

June 30, 2008

(Restated)

Amounts in LE.

Note

Interest and similar income

25

2,012,664,456

1,684,590,269

Interest and similar expense

25

(1,059,411,520)

(928,362,172)

Net Interest Income

953,252,936

756,228,097

Fees & Commissions Income

313,645,336

363,936,283

Fees & Commissions Expense

(31,987,769)

(23,332,096)

Net Income from Fees & Commissions

281,657,567

340,604,187

Dividends Income

124,448,940

124,108,529

Net Trading Income

26

319,080,163

229,790,721

Provisions

12&22

(61,497,940)

(164,354,750)

(Losses) Profits from Financial Investments

9

31,032,893

94,481,354

Administrative Expenses

(530,589,594)

(407,483,408)

Other Operating (Expenses) Income

10

(16,262,131)

132,414,060

Net Profit Before Tax

1,101,122,834

1,105,788,790

Income Tax

29

(176,553,162)

(105,794,579)

Deferred Tax

28&29

9,380,366

(32,270,421)

Net Profit After Tax

933,950,038

967,723,790

Earnings Per Share

Basic 

2.83

2.93

Diluted

2.76

2.90

CASH FLOW STATEMENT 1a

As of June. 30 2008

June 30, 2009

June 30, 2008

(Restated)

Amounts in LE.

Cash Flow From Operating Activities

Net Income Before Tax

1,101,122,834

1,105,788,790

Adjustments To Reconcile Net Income

To Net Cash Provided by operating Activities

Depreciation

94,192,342

65,209,394

Provisions (Formed during the period)

61,497,940

164,755,386

Trading Financial Investment Evaluation Differences

(20,074,180)

15,280,544

Impairment of Assets

(1,163,011)

-

Utilization of Provision (Other than Provision for Doubtful Debts)

(5,061,073)

(10,361,191)

Provisions no longer used

-

(94,706,704)

FCY Revaluation Differences of Provision Balances (Except Doubtful Debts)

1,916,734

(1,783,606)

Losses From Selling of Fixed Assets

(15,393,221)

(5,034,478)

Losses From Selling of financial Investments

(45,535,354)

(60,545,338)

Losses from Selling an investment subsidiary

-

(15,258,991)

FCY Revaluation Difference of Long Term Loans

308,628

729,177

Share Based Payments

40,268,360

28,850,246

Operating Profit Before Changes in Operating Assets and Liabilities

1,212,079,998

1,157,923,229

Net Decrease (Increase) in Assets

Due from banks

(1,910,710,733)

(1,015,132,615)

Treasury Bills & Other Governmental Notes 

2,216,468,549

55,781,462

Trading Financial Assets

(256,677,448)

(205,492,841)

Financial Derivatives (Net)

(54,273,344)

(28,138,148)

Loans & Overdrafts

(873,938,640)

(3,902,357,346)

Net Increase (Decrease) In Liabilities

Debit Balances & Other Assets

129,174,480

(629,643,698)

Due to Banks

3,360,421,235

1,741,061,367

Customer Deposits

1,991,336,877

6,103,350,907

Credit Balances & Other Liabilities

(543,208,000)

4,449,444

Net Cash Provided from Operating Activities

5,270,672,974

3,281,801,761

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

CASH FLOW STATEMENT 1b

As of June. 30 2009

June 30, 2009

June 30, 2008

Cash Flow From Investment Activities

Sales of subsidiaries & associated companies

64,368,072

18,126,009

Purchase of Fixed Assets, premises and Fitting-out of Branches

(82,211,182)

(80,245,398)

Redemption of Held-to-Maturity Financial Investments

48,739,592

157,040,360

Held to Maturity Financial Investment Purchases

(6,169,428)

-

Available for Sale Financial Investments

(4,766,623,773)

(1,129,488,697)

Net Cash (Used in) Provided from Investing Activities

(4,741,896,719)

(1,034,567,726)

Cash Flow From Financing Activities

Increase (Decrease) in Long Term Loans

(1,413,896)

(36,184,758)

Dividends Paid

(478,236,553)

(336,727,470)

-

Net Cash (Used in) Financing Activities

(479,650,449)

(372,912,228)

Net cash & cash equivalent changes

49,125,805

1,874,321,807

Beginning Balance of cash and cash equivalent

8,622,040,072

6,779,152,548

Cash & Cash equivalent Balance At the End of the period

8,671,165,877

8,653,474,355

Cash & Cash Equivalent are Represented as Follows

Cash and Due from Central Bank

4,114,701,615

7,218,498,485

Due From Banks

7,807,348,485

14,522,244,685

Treasury Bills & other Governmental Notes

11,154,734,981

2,776,871,582

Due from Banks (time deposits)

(7,627,665,005)

(14,279,351,149)

Treasury Bills with Maturity More than Three Months

(6,777,954,199)

(1,584,789,248)

Total Cash & Cash Equivalent

8,671,165,877

8,653,474,355

COMMERCIAL INTERNATIONAL BANK (EGYPT) S.A.E

STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY

As of June 30 2009

2008

Capital 

Legal Reserves

General Reserves

Retained Earnings*

Special Reserves

Reserves for A.F.S* Inv. Revaluation Diff.

Profits of the year

Reserve for Employee Stock ownership plan ESOP

Total

Beginning Balance

1,950,000,000

432,851,511

1,382,547,602

11,628,342

185,993,785

60,903,531

0

29,159,584

4,053,084,355

Derivatives revaluations settlement*

0

0

0

(13,571,026)

0

0

0

0

(13,571,026)

Capital Increase*

975,000,000

0

(975,000,000)

0

0

0

0

0

0

Net Profit of the year

0

0

0

0

0

0

1,615,100,458

0

1,615,100,458

Usage part of reserve

0

0

0

0

0

(81,215,930)

0

0

(81,215,930)

Reserve for employee stock ownership plan ESOP**

0

0

0

0

0

0

0

57,568,319

57,568,319

Ending Balance

2,925,000,000

432,851,511

407,547,602

(1,942,684)

185,993,785

(20,312,399)

1,615,100,458

86,727,903

5,630,966,176

2009

Capital 

Legal Reserves

General Reserves*

Retained Earnings*

Special Reserves

Reserves for A.F.S* Inv. Revaluation Diff.

Profits for the period

Reserve for Employee Stock ownership plan ESOP

Total

Beginning Balance

2,925,000,000

432,851,511

407,547,602

(1,942,684)

185,993,785

(20,312,399)

1,615,100,458

86,727,903

5,630,966,176

Transfer to Reserves

0

80,755,023

1,056,108,882

0

0

0

(1,136,863,905)

0

0

Dividends Paid

0

0

0

0

0

0

(478,236,553)

0

(478,236,553)

Net Profits of the Period

0

0

0

0

0

0

933,950,038

0

933,950,038

Addition from financial Investment Revaluation

0

0

0

0

0

64,529,337

64,529,337

Reserve for employee stock ownership plan ESOP

0

0

0

0

0

0

0

40,268,360

40,268,360

Ending Balance

2,925,000,000

513,606,534

1,463,656,484

(1,942,684)

185,993,785

44,216,938

933,950,438

126,996,263

6,191,477,358

* Note No. (23) 

** Note No. (31)

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UURRRKVRWAUR
Date   Source Headline
12th May 202610:18 amRNS1st Quarter Results
12th May 202610:16 amRNSCIB Consolidated Financial Statements 1Q26
12th May 202610:15 amRNS1Q26 Earnings Release
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Extraordinary GA March 2026
16th Mar 20267:00 amRNSResolutions Ordinary General Assembly March 2026
24th Feb 202612:31 pmRNSItems of Extraordinary GA
24th Feb 20267:00 amRNSPress Release dated 23th February 2026
19th Feb 20261:20 pmRNSItems of Extraordinary GA
19th Feb 20261:17 pmRNSInvitation to the Extraordinary GA 2026
19th Feb 20268:00 amRNSItems of OGA 2026
19th Feb 20268:00 amRNSInvitation to the OGA March 15
10th Feb 20267:00 amRNSCIB Summary of Board Resolution 9 Feb 2026
10th Feb 20267:00 amRNSFY25 Earnings Release
10th Feb 20267:00 amRNSCIB IFRS Consolidated Financial Statements FY25
15th Dec 20257:00 amRNSChange in Board of Directors
3rd Dec 20254:35 pmRNSCIB Bonus Shares Distribution 2025
4th Nov 20257:00 amRNSCIB Condensed Consolidated 3rd Quarter Results
4th Nov 20257:00 amRNSCIB 9M25 Earnings Release
4th Nov 20257:00 amRNS3rd Quarter Results
25th Sep 20253:55 pmRNSSummary of Resolutions - GAM September 2025
1st Sep 20257:02 amRNSInvitation to General Assembly September 2025
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Consolidated Financials
22nd Jul 20257:00 amRNSCIB 1H2025 Condensed Separate Financials
22nd Jul 20257:00 amRNS2Q25 Earnings Release
28th May 20256:00 pmRNSChanges to the Board of Directors
13th May 20257:00 amRNSSeparate- Q12025
13th May 20257:00 amRNS1Q25 Press Release
13th May 20257:00 amRNSConsolidated Financial Position at March 31.2025
24th Mar 20257:00 amRNSOrdinary General Assembly Resolutions Summary 2025
28th Feb 20257:00 amRNSGeneral Assembly 2025 - Discussion Items - amended
27th Feb 20257:47 amRNSInvitation to General Assembly 2025
27th Feb 20257:15 amRNSGeneral Assembly 2025 - Discussion Items
19th Feb 20257:00 amRNSCIB Annual Financial Report
19th Feb 20257:00 amRNSCIB FY2024 Earnings Release
6th Nov 20247:58 amRNSCIB gets regulatory approvals to changes to BoD
4th Nov 20247:00 amRNSEarnings Release 3Q.2024
4th Nov 20247:00 amRNSCIB-Separate Financial Statements 3Q.2024
4th Nov 20247:00 amRNSCIB-Consolidated Financial Statements 3Q.2024
1st Oct 20242:00 pmRNSCIB obtaining Long term loan from IFC
16th Sep 20248:00 amRNSChanges in CIB's Board of Directors
22nd Jul 20247:00 amRNSCIB H1-2024 Separate Financial Statements - E
22nd Jul 20247:00 amRNSH1.2024 Press Release
22nd Jul 20247:00 amRNSCIB H1-2024 Consolidated Financial Statements
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.